Can Flaxseed Supplementation Affect Circulating Adipokines in Adults? an Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials Publisher



Abbasi S¹ ; Karimi K² ; Hossein Moridpour A^{3, 4} ; Musazadeh V^{3, 4} ; Faghfouri AH⁵ ; Jozi H³ Show Affiliations
Source: Frontiers in Nutrition Published:2023

Abstract

Introduction: The findings of randomized controlled trials (RCTs) regarding the effect of flaxseed on adipokine concentrations are conflicting. Therefore, the present meta-analysis was conducted to provide definite and conclusive results. Methods: Systematically, Scopus, Embase, PubMed, Web of Science databases, and Google Scholar were searched for relevant literature published up to December 2022. Based on random-effect models, standard mean differences (SMDs) were calculated for net changes in adipokine concentrations. Results: Overall, 13 RCTs (15 arms) were eligible to be included. The results indicated that leptin was significantly reduced after the intervention with flaxseed supplement (SMD = −0.69, 95% CI: −1.37, −0.01; p = 0.048; I2 = 92.0%, p < 0.001). In addition, flaxseed supplements had no considerable effect on plasma adiponectin (SMD = 0.52, 95% CI: −0.20, 1.25, p = 0.159; I2 = 92.0%, p < 0.001). Discussion: Flaxseed significantly improves leptin but does not affect adiponectin concentrations. Additional future well-designed trials are required to further assess the potential benefits of flaxseed on adipokines in humans. Copyright © 2023 Abbasi, Karimi, Hossein Moridpour, Musazadeh, Faghfouri and Jozi.